Fracture incidence after 3 years of aromatase inhibitor therapy-Reference-Cited by-同舟云学术

Fracture incidence after 3 years of aromatase inhibitor therapy

Published:2014-04 Issue:4 Volume:25 Page:843-847
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bouvard B.,Soulié P.,Hoppé E.,Georgin-Mege M.,Royer M.,Mesgouez-Nebout N.,Lassalle C.,Cellier P.,Jadaud E.,Abadie-Lacourtoisie S.,Tuchais C.,Vinchon-Petit S.,Audran M.,Chappard D.,Legrand E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/4/843/16703274/mdu008.pdf

Reference20 articles.

1. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Aebi;Ann Oncol,2011

2. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial;Cuzick;Lancet Oncol,2010

3. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine- responsive early breast cancer: update of study BIG 1–98;Coates;J Clin Oncol,2007

4. Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper;Rizzoli;Osteoporos Int,2012

5. High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy;Bouvard;Ann Oncol,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of aromatase inhibitor–induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer;Osteoporosis International;2023-01-30

2. Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials;Therapeutic Advances in Medical Oncology;2023-01

3. Effects of Exercise on Vascular Toxicity Associated with Breast Cancer Treatment: A Narrative Review;Current Vascular Pharmacology;2023-01

4. From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors;Current Oncology;2021-02-26

5. Effects on the skeleton from medications used to treat nonskeletal disorders;Marcus and Feldman's Osteoporosis;2021